[PDF] Recommended Child and Adolescent Immunization Schedule

View - Download Recommended Child and Adolescent Immunization Schedule

Previous PDF

Next PDF

Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger

How to use the child and adolescent immunization

schedule Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American Academy of Pediatrics (www.aap.org), American Academy of Family Physicians (www.aafp.org), American College of Obstetricians and Gynecologists (www.acog.org), American College of Nurse-Midwives (www.midwife.org), American Academy of Physician Associates (www.aapa.org), and National Association of Pediatric Nurse Practitioners (www.napnap.org).

UNITED STATES

2023Vaccines in the Child and Adolescent Immunization Schedule*

VaccineAbbreviation(s)Trade name(s)

COVID-191vCOV-mRNAComirnaty®/Pflzer-

BioNTech COVID-19

Vaccine

SPIKEVAX®/Moderna

COVID-19 Vaccine

2vCOV-mRNAPflzer-BioNTech

COVID-19 Vaccine,

Bivalent

Moderna COVID-19

Vaccine, Bivalent

1vCOV-aPSNovavax COVID-19

Vaccine

Dengue vaccineDEN4CYDDengvaxia®

Diphtheria, tetanus, and acellular pertussis vaccineDTaPDaptacel®

Infanrix®

Diphtheria, tetanus vaccineDTNo trade name

Haemophilus influenzae type b vaccineHib (PRP-T)

Hib (PRP-OMP)

ActHIB®

Hiberix®

PedvaxHIB®

Hepatitis A vaccineHepAHavrix®

Vaqta®

Hepatitis B vaccineHepBEngerix-B®

Recombivax HB®

Human papillomavirus vaccineHPVGardasil 9®

Inuenza vaccine (inactivated)IIV4Multiple

Inuenza vaccine (live, attenuated)LAIV4FluMist® Quadrivalent Measles, mumps, and rubella vaccineMMRM-M-R II®

Priorix®

Meningococcal serogroups A, C, W, Y vaccineMenACWY-DMenactra®

MenACWY-CRMMenveo®

MenACWY-TTMenQuadfl®

Meningococcal serogroup B vaccineMenB-4CBexsero®

MenB-FHbpTrumenba®

Pneumococcal conjugate vaccinePCV13

PCV15

Prevnar 13®

Vaxneuvance™

Pneumococcal polysaccharide vaccinePPSV23Pneumovax 23®

Poliovirus vaccine (inactivated)IPVIPOL®

Rotavirus vaccineRV1

RV5

Rotarix®

RotaTeq®

Tetanus, diphtheria, and acellular pertussis vaccineTdapAdacel®

Boostrix®

Tetanus and diphtheria vaccineTdTenivac®

Tdvax™

Varicella vaccineVARVarivax®

Combination vaccines (use combination vaccines instead of separate injections when appropriate) DTaP, hepatitis B, and inactivated poliovirus vaccineDTaP-HepB-IPVPediarix® DTaP, inactivated poliovirus, and Haemophilus influenzae type b vaccineDTaP-IPV/HibPentacel® DTaP and inactivated poliovirus vaccineDTaP-IPVKinrix®

Quadracel®

DTaP, inactivated poliovirus, Haemophilus influenzae type b, and hepatitis B vaccine

DTaP-IPV-Hib-

HepB

Vaxelis®

Measles, mumps, rubella, and varicella vaccineMMRVProQuad®

Administer recommended vaccines if immunization history is incomplete or unknown. Do not restart or add doses to vaccine series for

extended intervals between doses. When a vaccine is not administered at the recommended age, administer at a subsequent visit.

The use of trade names is for identication purposes only and does not imply endorsement by the ACIP or CDC.

Report

Suspected cases of reportable vaccine-preventable diseases or outbreaks to your state or local health

department Clinically signiflcant adverse events to the Vaccine Adverse Event Reporting System (VAERS) at www.vaers.hhs.gov or 800-822-7967

Questions or comments

Contact www.cdc.gov/cdc-info or 800-CDC-INFO (800-232-4636), in English or Spanish, 8 a.m.-8 p.m. ET,

Monday through Friday, excluding holidays

Helpful information

Complete Advisory Committee on Immunization Practices (ACIP) recommendations: General Best Practice Guidelines for Immunization (including contraindications and precautions):

Vaccine information statements:

www.cdc.gov/vaccines/hcp/vis/index.html Manual for the Surveillance of Vaccine-Preventable Diseases (including case identication and outbreak response): www.cdc.gov/vaccines/pubs/surv-manual ACIP Shared Clinical Decision-Making Recommendations

Determine

recommended vaccine by age (Table

Determine

recommended interval for catch- up vaccination (Table

Assess need

for additional recommended vaccines by medical condition or other indication (Table

Review vaccine

types, frequencies, intervals, and considerations for special situations (Notes)

Review

contraindications and precautions for vaccine types (Appendix) Download the CDC Vaccine Schedules app for providers at

CS310020-C

Scan QR code

for access to online schedule

COVID-19 vaccination recommendations have changed. Find the latest recommendations at www.cdc.gov/covidschedule

These recommendations must be read with the notes that follow. For those who fall behind or start late, provide catch-up vaccination at the earliest opportunity as indicated by the green bars.

To determine minimum intervals between doses, see the catch-up schedule (Table 2).

VaccineBirth1 mo2 mos4 mos6 mos9 mos12 mos15 mos18 mos19-23 mos2-3 yrs4-6 yrs7-10 yrs11-12 yrs13-15 yrs16 yrs17-18 yrs

Hepatitis B (HepB)1

dose----- 2 dose -----W---------------------------- 3 dose ----------------------------

Rotavirus (RV): RV1 (2-dose series),

RV5 (3-dose series)

dose2 doseSee Notes

Diphtheria, tetanus, acellular pertussis

(DTaP <7 yrs) dose2 dose3 dose----- 4 dose ------5 dose

Haemophilus infiuenzae type b (Hib)1

dose2 doseSee Notes or 4 dose,

See Notes

Pneumococcal conjugate

(PCV13, PCV15) dose2 dose3 dose----- 4 dose -----

Inactivated poliovirus

(IPV <18 yrs) dose2 dose---------------------------- 3 dose ----------------------------4 dosequotesdbs_dbs7.pdfusesText_5

[PDF] immunization schedule 2019

[PDF] immunofluorescence protocol tissue

[PDF] immunologie approfondie cours pdf

[PDF] immunologie cours pdf 2eme année biologie

[PDF] immunologie cours pdf s5

[PDF] immunologie fondamentale cours pdf

[PDF] immunologie generale cours pdf

[PDF] immunologie medicale cours pdf

[PDF] impact factor pdf

[PDF] impact font

[PDF] impact font meme

[PDF] impact investing association

[PDF] impact investing in affordable housing in india

[PDF] impact investing in emerging markets

[PDF] impact investing metrics